• Search
  • Newsletters
  • Crossword
  • Notices
  • My Account
  • Subscribe
  • Sign In
The Irish Times
Wed, Apr 25, 2018

  • The Irish Times
  • News
  • Sport
  • Business
  • Opinion
  • Life & Style
  • Culture
  • More
  • Video
  • Podcasts
  • Executive Jobs
  • Search
  • Subscribe
  • My Account
  • Sign In
  • Companies
  • Health & Pharma
  • Financial Services
  • Agribusiness & Food
  • Energy & Resources
  • Manufacturing
  • Media & Marketing
  • Retail & Services
  • Transport & Tourism
All Business
  • The Economy
    • Budget 2018
    • Small Business
  • Your Money
    • Personal Finance
    • Exchange Rates
    • Markets
    • Funds Tracker
  • Companies
    • Financial Services
    • Agribusiness & Food
    • Energy & Resources
    • Health & Pharma
    • Manufacturing
    • Media & Marketing
    • Retail & Services
    • Transport & Tourism
  • Technology
    • How to ...
    • Data Privacy
    • Tech Tools
  • Work
    • Businessperson Awards
  • Commercial Property
    • Construction
  • Comment
    • Columnists
  • Innovation
  • Specials
    • Paradise Papers
    • Entrepreneur of the Year
    • AIB Start-up Academy
  • Podcasts
    • Business Podcast
    • Tech & Innovation
  • Partner Sites
    • Top1000
By using this website, you consent to our use of cookies. For more information on cookies see our Cookie Policy.
PCI’s customers were seeking a response to Brexit from the company. Photograph: iStock Brexit prompts US pharma business to invest in Louth and Meath
  • Health & Pharma
  • Elaine Keogh
  • April 25, 2018, 15:22

PCI plans to create up to 130 new jobs over five years

Shares in Takeda tumbled further on Wednesday on news of the Shire deal. Photograph: Suzanne Plunkett/Reuters Shire to recommend $64bn Takeda deal to shareholders
  • Health & Pharma
  • April 25, 2018, 06:50

Acquisition would be largest ever outbound deal by Japanese company

Shire’s board “is considering its position” on a new bid from Takeda. Shire considers new offer from Takeda Pharmaceutical
  • Health & Pharma
  • April 24, 2018, 14:38

Japanese drugmaker revises $60bn bid for biotechnology company

HiberGene chief executive Brendan Farrell said the company was halfway through its latest fundraising round. Irish firm HiberGene Diagnostics unveils new rapid test for meningitis
  • Health & Pharma
  • Ciara O'Brien
  • April 24, 2018, 10:32

Company raising €5 million for product development and global commercialisation

Prothena is now discontinuing development of the antibody-based medicine for the condition. Dublin based biotech Prothena plunges as key drug fails
  • Health & Pharma
  • April 24, 2018, 08:15

Elan spin-out plunged 70% after its main drug failed in a crucial clinical trial

MSD has told the court that Clonmel Healthcare, part of Stada AG publicly quoted group based in Germany, is infringing its patent rights. Photograph: Robbie Reynolds Sale of rival MSD cholesterol drug breaching patent rights, court told
  • Health & Pharma
  • April 23, 2018, 16:56

Clonmel Healthcare launched generic version of MSD cholesterol drug last week

Irish patients are being denied access to nine drugs that are widely available across Europe, largely on cost grounds. Delays on new drugs, Smyths Toys expand in Europe and entrepreneur awards shortlist
  • Health & Pharma
  • Michael McAleer
  • April 23, 2018, 06:41

Business Today: the best news, analysis and comment from ‘The Irish Times’ business desk

Photograph: iStock Price pressure keeps nine new drugs from Irish patients
  • Health & Pharma
  • Dominic Coyle
  • April 23, 2018, 05:55

Cancer drugs feature in list of therapies waiting HSE approval on cost grounds

Allergan had about $30.1bn in debt and $6.45bn in cash at the end of the year Allergan will not bid for Irish rare diseases specialist Shire
  • Health & Pharma
  • Colin Gleeson
  • April 20, 2018, 07:16

Reports had suggested pharma company would rival Takeda’s $60bn offer

Takeda said it offered had £46.50 (€53.46) a share in cash and stock last week for Shire in a bid to extend its global reach. Shire shares surge as Allergan considers bid
  • Health & Pharma
  • April 19, 2018, 15:43

Takeda Pharmaceutical has tabled $60 billion offer

Aimée Madden of Clinishift, winner of the 2018 Bolton Trust / PwC Innovation Awards, pictured with PwC managing partner Feargal O’Rourke (left), Minister for Finance Paschal Donohoe and Bolton Trust chairman John Lauder. Clinishift founder Aimée Madden wins Bolton Trust / PwC innovation award
  • Health & Pharma
  • Laura Slattery
  • April 19, 2018, 12:45

Company behind hospital software that allocates overtime shifts receives €10,000 prize

Artist’s impression of new MSD site at Swords, expanded  to 43,000sq m from previous 31,000sq m plant. Pharma giant seeks planning for Swords plant
  • Health & Pharma
  • Dominic Coyle
  • April 19, 2018, 05:00

Biotech facility to employ 350 on repurposed and expanded Dublin site

Former INM chairman Leslie Buckley, who is reported in court documents to have passed on confidential information to INM shareholder Denis O’Brien about communications minister Denis Naughten’s plans to refer the Celtic Media merger to the regulator. Photograph: Brenda Fitzsimons INM and the minister, budget insight, the iPhone skewing growth figures and Ireland becomes a Facebook friend
  • Health & Pharma
  • Dominic Coyle
  • April 18, 2018, 06:40

Business Today: the best news, analysis and comment from ‘The Irish Times’ business desk

Johnson & Johnson said it plans to streamline its global supply chain and expects pretax savings of $600 million to $800 million by 2022 J&J raises sales forecast but keeps profit outlook unchanged; shares drop
  • Health & Pharma
  • April 17, 2018, 21:24

Healthcare conglomerate reported better-than-expected profit in the first quarter

Integumen was set up in 2016 and bought out a healthcare products business from Venn Life Sciences. Photograph: Getty Images Dalkey-based health tech firm in reverse takeover
  • Health & Pharma
  • Peter Hamilton
  • April 16, 2018, 18:26

Integumen and Cellulac set to combine with a £7.5m share placing in the pipeline

Alkermes reckons more than eight million people in the US alone suffer from a major depressive disorder. File photograph: Getty Images Alkermes secures US watchdog U-turn on depression drug
  • Health & Pharma
  • Dominic Coyle
  • April 16, 2018, 18:07

Food and Drug Administration accepts filing from Irish pharma group fortnight after refusal

Two sources with direct knowledge of the matter said last week that Takeda had sounded out its major creditors for loans to fund a potential Shire bid.  Photograph:  Suzanne Plunkett/Reuters Shire sells cancer drugs to Servier for $2.4bn as Takeda circles
  • Health & Pharma
  • April 16, 2018, 10:36

Divestment of the cancer business may be a deterrent for Takeda

Immunotherapies have been a major focus of cancer research in recent years Dublin company Inflection Biosciences signs research deal with Trinity College
  • Health & Pharma
  • Dominic Coyle
  • April 16, 2018, 05:40

Start-up working on way to block spread of cancer cells in patients with aggressive breast cancer

  • 1
  • 2
  • 3
  • 4
  • Next ›

Subscriber Only

If you have two children, that means anything above €620,000 will be subject to inheritance tax – formally known as Capital Acquisitions Tax – at 33%. File photograph: Getty Images How best to tackle the pressing matter of inheritance tax
Facebook’s European headquarters in the Dublin docklands. Photograph: Aidan Crawley/Bloomberg via Getty Images Ireland’s unanswered questions on the Facebook scandal
A group of BBC journalists attend a hearing into gender pay, in support of Carrie Gracie, who resigned  as BBC China editor in January. Photograph: Daniel Leal-Olivas Media should mind its gender pay gap and embrace mandatory reporting

Most Read in Business

1 Sean Fitzpatrick’s wife claiming about €6m in assets
2 Government votes against AIB bonus plan at meeting
3 Ulster Bank and AIB responsible for extra 3,400 in tracker scandal
4 Brexit prompts US pharma business to invest in Louth and Meath
5 Latest banking IT meltdown leaves 1.9m TSB customers high and dry
Real news has value SUBSCRIBE
Subscribe on iTunes Follow on Soundcloud Listen on Stitcher

Latest Business

Brexit prompts US pharma business to invest in Louth and Meath 15:22
Ulster Bank and AIB responsible for extra 3,400 in tracker scandal 15:19
Sean Fitzpatrick’s wife claiming about €6m in assets 14:31
Thirteen per cent of cigarettes sold are contraband, says Revenue 13:53
Businesses more concerned about staff and data than Brexit 13:08
Search executive
jobs on irishtimes.com

Columnists

Fiona Walsh Fiona Walsh -

Latest banking IT meltdown leaves 1.9m TSB customers high and dry

Cliff Taylor Cliff Taylor -

Apple’s billions will merely be ‘resting in our account’

Opinion & Analysis

 Terry Buckley: will step down as director of Independent News & Media Another Buckley calls time at INM
A computer-generated image of the WB Yeats Act of god or foreseeable issue for Irish Continental Group?
Irish Central Bank governor Philip Lane at the IMF spring meeting in Washington. Photograph: Reuters/Yuri Gripas Lane follows Brown and promises no return to boom and bust

News - direct to your inbox

Which Daily Digest would you like?

Brendan O’Callaghan is named Pharma Leader 2017 at the Pharma Industry Awards Brendan O’Callaghan is named Pharma Leader 2017 at the Pharma Industry Awards

23 trophies were presented to winning companies at a gala award ceremony held in the Clayton Hotel in Dublin on the 5th of October

Facebook

Subscribe
About Us
Policy & Terms
Subscribe
  • Why Subscribe?
  • Subscription Bundles
  • Gift Subscriptions
  • Home Delivery
Irish Times Products & Services
  • ePaper
  • eBooks
  • Crosswords
  • Newspaper Archive
  • Email Alerts & Newsletters
  • Article Archive
  • Executive Jobs
  • Page Sales
  • Photo Sales
About Us
  • Advertise
  • Contact Us
  • The Irish Times Trust CLG
  • Careers
Download on the App Store Download on Google Play
  • Our Partners
  • Rewarding Times
  • MyHome.ie
  • Irish Racing
  • Top 1000
  • MyAntiques.ie
  • The Gloss
  • Irish Times Training
  • Terms & Conditions
  • Privacy Policy
  • Cookie Information
  • Community Standards
  • Copyright
  • FAQs
© 2015 THE IRISH TIMES

Sign In

Forgot Password?
Don't have an account?
Subscribe

  • Subscriber Only Articles
  • The ePaper
  • Subscriber Rewards
  • Subscriber Tour
  • Breaking news app
  • IT Sunday
  • My Account
  • eBooks
  • Email Newsletters
  • Crossword Club
  • Newspaper Archive
  • Sign Out
SUBSCRIBE

Wed 25/4/2018
  • News
    • Ireland
    • World
    • Politics
    • Crime & Law
    • Social Affairs
    • Health
    • Education
    • Brexit
    • Subscriber Only
  • Sport
    • Rugby
    • Soccer
    • Gaelic Games
    • Golf
    • Racing
    • Other Sports
    • Women in Sport
    • Comment
  • Business
    • The Economy
    • Your Money
    • Companies
    • Technology
    • Work
    • Commercial Property
    • Comment
  • Opinion
    • Editorials
    • Letters
    • Columnists
    • An Irishman's Diary
    • Opinion & Analysis
    • Martyn Turner
  • Life & Style
    • Food & Drink
    • Homes & Property
    • Health & Family
    • People
    • Travel
    • Motors
    • Fashion
    • Abroad
  • Culture
    • Books
    • Film
    • Music
    • Stage
    • Art & Design
    • TV, Radio, Web
    • Treibh
  • More
    • You are what you read
    • eBooks
    • Offers
    • Jobs
    • Family Notices
    • Competitions
  • Video
  • Podcasts
    • Inside Politics
    • World View
    • Second Captains
    • Business
    • Róisín Meets
    • Off Topic
    • The Women's Podcast
  • Executive Jobs
  • Crosswords
  • Newsletters
  • Notices
Forgot Password?

Invalid email or password.

Not an Irish Times subscriber? Subscribe
  • Subscriber Only Articles Specially selected and available only to our subscribers
  • Subscriber Rewards Exclusive offers, discounts and invitations
  • Subscriber Tour Explore the features of your subscription
  • Crossword Club Digital Simplex and Crosaire crosswords
  • Newspaper Archive 150 years of Irish Times journalism
  • My Account Manage your account
  • IT Sunday Your weekly email exclusively curated for subscribers
  • eBooks Carefully curated selections of Irish Times writing
  • Email Newsletters Sign up to get the stories you want delivered to your inbox
  • The ePaper An exact digital replica of the printed paper
  • Breaking news app Our Apple and Android apps to read on the go
  • Sign Out